DK2308869T3 - Azolforbindelse - Google Patents

Azolforbindelse

Info

Publication number
DK2308869T3
DK2308869T3 DK09797891.0T DK09797891T DK2308869T3 DK 2308869 T3 DK2308869 T3 DK 2308869T3 DK 09797891 T DK09797891 T DK 09797891T DK 2308869 T3 DK2308869 T3 DK 2308869T3
Authority
DK
Denmark
Prior art keywords
azole compound
azole
compound
Prior art date
Application number
DK09797891.0T
Other languages
English (en)
Inventor
Satoshi Aoki
Ryosuke Munakata
Noriyuki Kawano
Kiyohiro Samizu
Hiromasa Oka
Takahiro Ishii
Takashi Sugane
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of DK2308869T3 publication Critical patent/DK2308869T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK09797891.0T 2008-07-14 2009-07-13 Azolforbindelse DK2308869T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008182251 2008-07-14
PCT/JP2009/062680 WO2010007966A1 (ja) 2008-07-14 2009-07-13 アゾール化合物

Publications (1)

Publication Number Publication Date
DK2308869T3 true DK2308869T3 (da) 2012-10-08

Family

ID=41550369

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09797891.0T DK2308869T3 (da) 2008-07-14 2009-07-13 Azolforbindelse

Country Status (21)

Country Link
US (1) US8207199B2 (da)
EP (1) EP2308869B1 (da)
JP (1) JP5423675B2 (da)
KR (1) KR101566051B1 (da)
CN (1) CN102099354B (da)
AU (1) AU2009273105B2 (da)
BR (1) BRPI0915876B1 (da)
CA (1) CA2730793C (da)
CY (1) CY1113439T1 (da)
DK (1) DK2308869T3 (da)
ES (1) ES2393245T3 (da)
HR (1) HRP20120969T1 (da)
IL (1) IL210226A (da)
MX (1) MX2011000415A (da)
PL (1) PL2308869T3 (da)
PT (1) PT2308869E (da)
RU (1) RU2493154C2 (da)
SI (1) SI2308869T1 (da)
TW (1) TWI434842B (da)
WO (1) WO2010007966A1 (da)
ZA (1) ZA201100139B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011085216A2 (en) 2010-01-08 2011-07-14 Ironwood Pharmaceuticals, Inc. Use of faah inhibitors for treating parkinson's disease and restless legs syndrome
WO2011123719A2 (en) 2010-03-31 2011-10-06 Ironwood Pharmaceuticals, Inc. Use of faah inhibitors for treating abdominal, visceral and pelvic pain
JP2013147430A (ja) * 2010-04-28 2013-08-01 Astellas Pharma Inc 夜間頻尿の予防又は治療剤
TW201206440A (en) * 2010-04-28 2012-02-16 Astellas Pharma Inc Prophylactic or therapeutic agent for diseases associated with pains in urinary organs
FR2974365B1 (fr) 2011-04-20 2017-08-25 Centre Nat De La Rech Scient (C N R S) 1,2,3-triazoles 1,4-disubstituees, leurs procedes de preparation et leurs utilisations diagnostiques et therapeutiques
DE102012018115A1 (de) 2012-09-13 2014-03-13 Matthias Lehr Aryl-N-(arylalkyl)carbamate als Hemmstoffe der Fatty Acid Amide Hydrolase
EP2905279A4 (en) * 2012-10-02 2016-04-20 Sumitomo Dainippon Pharma Co Ltd imidazole
DE102013016573A1 (de) 2013-10-04 2015-04-09 Matthias Lehr 1-Tetrazolylpropan-2-one als Inhibitoren von cytosolischer Phospholipase A2 und Fatty Acid Amide Hydrolase, insbesondere geeignet zur topischen Anwendung
CN106632260B (zh) * 2016-09-29 2019-04-26 上海天慈生物谷生物工程有限公司 一种小分子激酶抑制剂的制备方法
WO2018081167A1 (en) * 2016-10-24 2018-05-03 Yumanity Therapeutics Compounds and uses thereof
CA3083000A1 (en) * 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. Compounds and uses thereof
CN108409727A (zh) * 2017-10-25 2018-08-17 巨德峰 一种脂肪酰胺水解酶抑制剂及其制备方法
JP2021522253A (ja) 2018-04-25 2021-08-30 ユマニティ セラピューティクス,インコーポレーテッド 化合物及びその使用
CN108912112A (zh) * 2018-08-14 2018-11-30 李敬敬 一种化合物、制备方法以及其在治疗疼痛中的应用
CA3127791A1 (en) 2019-01-24 2020-07-30 Yumanity Therapeutics, Inc. Compounds and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69722360T2 (de) * 1996-06-29 2003-11-27 Samjin Pharm, Co. Piperazin-derivate und verfahren zu ihrer herstellung
AU2002351731A1 (en) 2001-12-14 2003-06-30 Novo Nordisk A/S Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
PL373970A1 (en) 2002-02-08 2005-09-19 Bristol-Myers Squibb Company (oxime)carbamoyl fatty acid amide hydrolase inhibitors
EP1558591B1 (en) 2002-10-07 2014-05-07 The Regents of The University of California Modulation of anxiety through blockade of anandamide hydrolysis
FR2854633B1 (fr) * 2003-05-07 2005-06-24 Sanofi Synthelabo Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique
GB0325956D0 (en) 2003-11-06 2003-12-10 Addex Pharmaceuticals Sa Novel compounds
FR2866884B1 (fr) 2004-02-26 2007-08-31 Sanofi Synthelabo Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique
TW200633990A (en) 2004-11-18 2006-10-01 Takeda Pharmaceuticals Co Amide compound
ES2528674T3 (es) * 2005-02-17 2015-02-11 Astellas Pharma Inc. Piperidina y carboxilatos de piperacina como inhibidores de FAAH
GB2424955B (en) 2005-04-09 2008-07-16 Siemens Ag Flow meter with conductive coating
GB0510139D0 (en) 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B1
WO2007005510A1 (en) 2005-06-30 2007-01-11 Janssen Pharmaceutica N.V. N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase
US7812025B2 (en) * 2005-08-12 2010-10-12 Takeda Pharmaceutical Company Limited Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder

Also Published As

Publication number Publication date
SI2308869T1 (sl) 2012-12-31
US20110118311A1 (en) 2011-05-19
RU2011105151A (ru) 2012-08-20
TWI434842B (zh) 2014-04-21
BRPI0915876B1 (pt) 2019-07-09
HRP20120969T1 (hr) 2012-12-31
CY1113439T1 (el) 2016-06-22
EP2308869A1 (en) 2011-04-13
WO2010007966A1 (ja) 2010-01-21
AU2009273105A1 (en) 2010-01-21
CN102099354B (zh) 2013-07-10
ZA201100139B (en) 2012-03-28
EP2308869B1 (en) 2012-09-19
KR101566051B1 (ko) 2015-11-04
IL210226A (en) 2014-07-31
IL210226A0 (en) 2011-03-31
TW201014840A (en) 2010-04-16
US8207199B2 (en) 2012-06-26
MX2011000415A (es) 2011-03-15
PL2308869T3 (pl) 2013-02-28
JPWO2010007966A1 (ja) 2012-01-05
CN102099354A (zh) 2011-06-15
CA2730793A1 (en) 2010-01-21
KR20110038671A (ko) 2011-04-14
JP5423675B2 (ja) 2014-02-19
ES2393245T3 (es) 2012-12-19
AU2009273105B2 (en) 2013-09-05
CA2730793C (en) 2014-12-30
PT2308869E (pt) 2012-12-06
EP2308869A4 (en) 2011-07-27
BRPI0915876A2 (pt) 2015-11-03
RU2493154C2 (ru) 2013-09-20

Similar Documents

Publication Publication Date Title
DK2288375T3 (da) Pegylerede insulin-lispro-forbindelser
BRPI0920707A2 (pt) compostos
DK2242759T3 (da) Forbindelser
DK2308869T3 (da) Azolforbindelse
SMT201600045B (it) Composti tetraciclinici c7-fluoro sostituiti
BRPI0914746A2 (pt) composições fungicidas
BRPI0918602A2 (pt) composto (i)
DK2340021T3 (da) Substituerede pyrrolidin-2-carboxamider
BRPI0907376A2 (pt) Fotobiorretador
BRPI0914649A2 (pt) Piprazolo-quinazolinas
BRPI0906705A2 (pt) Composto heterocíclicos
DK2297162T3 (da) Forbindelser
DK2300238T3 (da) Skyggebillede-sikkerhedstræk
BRPI0916432A2 (pt) compostos
BRPI0907522A2 (pt) biarlamidas
BRPI0912716A2 (pt) composto.
BRPI0923592A2 (pt) composto
BRPI0922098A2 (pt) composto inorgânicos
BRPI0909634A2 (pt) 2-aminoquinolinas
BRPI0911393A2 (pt) composto de 5-hidroxipirimidina-4-carboxamida
BRPI0907863A2 (pt) pirrolopirimidinacarboxamidas
BRPI0909637A2 (pt) 2-aminoquinolinas
AT507449A3 (de) Dämmstoffbefestiger
DK2206698T3 (da) Ethynylindolforbindelser
BRPI0922152A2 (pt) Compostos